BiotechTube
Home/Pipeline/Viz Oncology

Viz Oncology

Oncology (unspecified)

CommercialActive

Key Facts

Indication
Oncology (unspecified)
Phase
Commercial
Status
Active
Company
Viz.ai

About Viz.ai

Viz.ai is a pioneering AI-powered care coordination platform company founded in 2016. It has developed a comprehensive suite of FDA-cleared algorithms that auto-detect suspected diseases from medical scans (CT, EKG, echo) and facilitate real-time communication among care teams to accelerate treatment. The company serves both healthcare providers and life sciences partners, with solutions spanning neurovascular, cardiovascular, vascular, trauma, oncology, and radiology. Viz.ai is a private, revenue-generating company positioned at the intersection of AI diagnostics and clinical workflow optimization.

View full company profile

Therapeutic Areas

NeurologyCardiologyVascularTraumaOncologyRadiology

Other Oncology (unspecified) Drugs

DrugCompanyPhase
Oncology Vaccine ProgramCHAIN BiotechPre-clinical
Cancer Immunotherapy NanotherapeuticFlashpoint TherapeuticsPhase 1
GRWD5769Greywolf TherapeuticsPhase 1/2
Platform-derived Program(s)Immuto ScientificDiscovery/Pre-clinical
MBT Oncology ProgramIonic PharmaceuticalsPre-clinical
ISB 2301Ichnos Glenmark InnovationPreclinical
GRC 65327Ichnos Glenmark InnovationPreclinical
Platform-Derived PipelinePhinomicsDiscovery/Pre-clinical
Lead Small-Molecule InhibitorEris BiotechPre-clinical
Orotecan™Edison OncologyPhase 1/2a
DDX3 Inhibitor (Oncology)Lead Discovery SienaDiscovery
Roginolisib (IOA-244)iOncturaPhase 2